Diabetes Mellitus Community Based Screening in Minority Populations



Status:Completed
Conditions:Diabetes
Therapuetic Areas:Endocrinology
Healthy:No
Age Range:18 - Any
Updated:4/2/2016
Start Date:June 2012
End Date:January 2013
Contact:Kelly Lamb, MA
Email:lambkellyann@gmail.com
Phone:617-947-9095

Use our guide to learn which trials are right for you!

The purpose of the type II diabetes (T2D) screening study is to improve diabetes care in
minority communities by identifying undiagnosed and uncontrolled T2D patients, as well as
help patients without a regular primary care physician (PCP) find one within their
community. These goals will be achieved first through a glucose measurement. Individuals
with a high glucose measurement will be confirmed with a rapid hemoglobin A1c (HgA1c) test.
The HgA1c test will tell us about the patients average blood sugar over the past 3 months,
which will allow us to immediately diagnose new and uncontrolled type II diabetics. All
participants will fill out a survey on healthcare seeking behaviors before glucose testing.
All patients who enter the study will receive education on T2D and the value of regularly
visiting their PCP, and will be provided a list of PCP currently accepting new patients
within a 3 mile radius. Follow-up visits at 4 and 8 months will help us determine the
success this community based screening.

The investigators hypothesis is that community based screening designed with adequate
education and follow-up, and performed by qualified medical professionals will improve
diabetes care in minority communities as assessed through hemoglobin A1c levels over 8
months, and in the change in the number patients who visit/obtain their PCP within the study
period.


Inclusion Criteria:

- Adults 18 and older

Exclusion Criteria:

- Type I Diabetes.

- Women who are currently pregnant.
We found this trial at
1
site
Dorchester, Massachusetts 02124
?
mi
from
Dorchester, MA
Click here to add this to my saved trials